| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |